Jane Street Group, LLC Ocugen, Inc. Transaction History
Jane Street Group, LLC
- $384 Billion
- Q1 2025
A detailed history of Jane Street Group, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 65,388 shares of OCGN stock, worth $63,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,388
Previous 65,388
-0.0%
Holding current value
$63,426
Previous $46,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding OCGN
# of Institutions
119Shares Held
75.2MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$17.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.7MShares$16.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$6.68 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$5.75 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.24 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $210M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...